297 related articles for article (PubMed ID: 15574741)
21. Peroxisome proliferator-activated receptor γ ligands retard cultured vascular smooth muscle cells calcification induced by high glucose.
Zhou YB; Zhang J; Peng DQ; Chang JR; Cai Y; Yu YR; Jia MZ; Wu W; Guan YF; Tang CS; Qi YF
Cell Biochem Biophys; 2013 Jul; 66(3):421-9. PubMed ID: 23274912
[TBL] [Abstract][Full Text] [Related]
22. Genetic Deletion of Neuronal PPARγ Enhances the Emotional Response to Acute Stress and Exacerbates Anxiety: An Effect Reversed by Rescue of Amygdala PPARγ Function.
Domi E; Uhrig S; Soverchia L; Spanagel R; Hansson AC; Barbier E; Heilig M; Ciccocioppo R; Ubaldi M
J Neurosci; 2016 Dec; 36(50):12611-12623. PubMed ID: 27810934
[TBL] [Abstract][Full Text] [Related]
23. Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists.
Combs CK; Johnson DE; Karlo JC; Cannady SB; Landreth GE
J Neurosci; 2000 Jan; 20(2):558-67. PubMed ID: 10632585
[TBL] [Abstract][Full Text] [Related]
24. Specific thiazolidinediones inhibit ovarian cancer cell line proliferation and cause cell cycle arrest in a PPARγ independent manner.
Al-Alem L; Southard RC; Kilgore MW; Curry TE
PLoS One; 2011 Jan; 6(1):e16179. PubMed ID: 21283708
[TBL] [Abstract][Full Text] [Related]
25. Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice.
Skerrett R; Pellegrino MP; Casali BT; Taraboanta L; Landreth GE
J Biol Chem; 2015 Aug; 290(35):21591-602. PubMed ID: 26163517
[TBL] [Abstract][Full Text] [Related]
26. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
[TBL] [Abstract][Full Text] [Related]
27. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
Kim KR; Choi HN; Lee HJ; Baek HA; Park HS; Jang KY; Chung MJ; Moon WS
Oncol Rep; 2007 Oct; 18(4):825-32. PubMed ID: 17786342
[TBL] [Abstract][Full Text] [Related]
28. Thyroid hormone receptor beta mutants: Dominant negative regulators of peroxisome proliferator-activated receptor gamma action.
Araki O; Ying H; Furuya F; Zhu X; Cheng SY
Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16251-6. PubMed ID: 16260719
[TBL] [Abstract][Full Text] [Related]
29. Epigallocatechin Gallate Attenuates β-Amyloid Generation and Oxidative Stress Involvement of PPARγ in N2a/APP695 Cells.
Zhang ZX; Li YB; Zhao RP
Neurochem Res; 2017 Feb; 42(2):468-480. PubMed ID: 27889855
[TBL] [Abstract][Full Text] [Related]
30. Cyanidin 3-O-β-glucopyranoside activates peroxisome proliferator-activated receptor-γ and alleviates cognitive impairment in the APP(swe)/PS1(ΔE9) mouse model.
Song N; Zhang L; Chen W; Zhu H; Deng W; Han Y; Guo J; Qin C
Biochim Biophys Acta; 2016 Sep; 1862(9):1786-800. PubMed ID: 27240542
[TBL] [Abstract][Full Text] [Related]
31. Rosiglitazone ameliorates cisplatin-induced renal injury in mice.
Lee S; Kim W; Moon SO; Sung MJ; Kim DH; Kang KP; Jang YB; Lee JE; Jang KY; Park SK
Nephrol Dial Transplant; 2006 Aug; 21(8):2096-105. PubMed ID: 16728429
[TBL] [Abstract][Full Text] [Related]
32. PPARγ/RXRα-induced and CD36-mediated microglial amyloid-β phagocytosis results in cognitive improvement in amyloid precursor protein/presenilin 1 mice.
Yamanaka M; Ishikawa T; Griep A; Axt D; Kummer MP; Heneka MT
J Neurosci; 2012 Nov; 32(48):17321-31. PubMed ID: 23197723
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic potential of thiazolidinediones in activation of peroxisome proliferator-activated receptor gamma for monocyte recruitment and endothelial regeneration.
Tanaka T; Fukunaga Y; Itoh H; Doi K; Yamashita J; Chun TH; Inoue M; Masatsugu K; Saito T; Sawada N; Sakaguchi S; Arai H; Nakao K
Eur J Pharmacol; 2005 Jan; 508(1-3):255-65. PubMed ID: 15680279
[TBL] [Abstract][Full Text] [Related]
34. Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
Magenta G; Borenstein X; Rolando R; Jasnis MA
BMC Cancer; 2008 Feb; 8():47. PubMed ID: 18261208
[TBL] [Abstract][Full Text] [Related]
35. The nuclear cofactor receptor interacting protein-140 (RIP140) regulates the expression of genes involved in Aβ generation.
Blondrath K; Steel JH; Katsouri L; Ries M; Parker MG; Christian M; Sastre M
Neurobiol Aging; 2016 Nov; 47():180-191. PubMed ID: 27614112
[TBL] [Abstract][Full Text] [Related]
36. GM1 ganglioside regulates the proteolysis of amyloid precursor protein.
Zha Q; Ruan Y; Hartmann T; Beyreuther K; Zhang D
Mol Psychiatry; 2004 Oct; 9(10):946-52. PubMed ID: 15052275
[TBL] [Abstract][Full Text] [Related]
37. Troglitazone, a peroxisome proliferator-activated receptor-gamma agonist, decreases tau phosphorylation in CHOtau4R cells.
d'Abramo C; Ricciarelli R; Pronzato MA; Davies P
J Neurochem; 2006 Aug; 98(4):1068-77. PubMed ID: 16787414
[TBL] [Abstract][Full Text] [Related]
38. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
Guan YF; Zhang YH; Breyer RM; Davis L; Breyer MD
Neoplasia; 1999 Oct; 1(4):330-9. PubMed ID: 10935488
[TBL] [Abstract][Full Text] [Related]
39. Role of peroxisome proliferator-activated receptor gamma in amyloid precursor protein processing and amyloid beta-mediated cell death.
d'Abramo C; Massone S; Zingg JM; Pizzuti A; Marambaud P; Dalla Piccola B; Azzi A; Marinari UM; Pronzato MA; Ricciarelli R
Biochem J; 2005 Nov; 391(Pt 3):693-8. PubMed ID: 15946122
[TBL] [Abstract][Full Text] [Related]
40. Troglitazone, the peroxisome proliferator-activated receptor-gamma agonist, induces antiproliferation and redifferentiation in human thyroid cancer cell lines.
Park JW; Zarnegar R; Kanauchi H; Wong MG; Hyun WC; Ginzinger DG; Lobo M; Cotter P; Duh QY; Clark OH
Thyroid; 2005 Mar; 15(3):222-31. PubMed ID: 15785241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
